Latest Funding News

Future Battery Minerals has revealed significant shallow gold intercepts and broad surface anomalies at its Burbanks East Project, with drilling at the nearby Miriam Project scheduled to start in July 2025.

Paradigm Biopharmaceuticals has locked in a $27 million USD convertible note facility to fully fund its pivotal Phase 3 trial for knee osteoarthritis, ensuring operational momentum through key clinical milestones.

Santana Minerals has released an updated Pre-Feasibility Study for its Bendigo-Ophir Gold Project, showcasing robust economics with a 13.8-year mine life and strong production profile. The study highlights significant capital efficiency improvements and a refined mining strategy.

BlackRock Investment Management (Australia) Limited has announced the final confirmed cash distributions for nine Australian domiciled iShares ETFs, outlining key dates and investor requirements.

Proteomics International, alongside key partners, is investing $6 million to expand the WA Proteomics Facility, aiming to establish a nationally accredited platform for industrial-scale protein biomarker analysis in medicine and agriculture.

Laramide Resources has announced a $10 million private placement to fund critical US permitting and corporate activities, with major shareholder Boss Energy backing the raise.

WIN Metals has sold its non-core nickel rights and infrastructure at Munda to Auric Mining for $1.4 million, redirecting capital to advance its Butchers Creek Gold Project in the Kimberley region.

InvestSMART Funds Management has updated the Distribution Reinvestment Plan rules for the Intelligent Investor Equity Growth Fund Active ETF, effective July 1, 2025, enhancing unitholder flexibility and fund capital management.

Krakatoa Resources Limited has secured an additional $357,000 through a top-up placement, boosting its recent capital raise to $1.659 million. The company also provides a comprehensive update on its Zopkhito Project in Georgia, alongside an extensive review of associated risks.

Rhythm Biosciences has obtained a $1 million non-dilutive loan backed by its FY2025 R&D Tax Incentive rebate, aiming to accelerate the commercial rollout of its ColoSTAT® test and expand its geneType™ platform.

JPMorgan Asset Management has released updated estimated cash distributions for five of its active ETFs for the financial year ended June 30, 2025, outlining key dates and investor participation details.

Mt Malcolm Mines has successfully completed a $1.04 million entitlement offer and raised an additional $200,000 through a placement, bolstering funds for its Western Australian gold projects.